People

Joyanna Gamble-George
Joyonna Gamble-George, MHA, PhD
Yale School of Public Health - Associate Research Scientist in Public Health
Email: joyonna.gamble-george@yale.edu
Education
PhD, Neuroscience, Vanderbilt University School of Medicine
MHA, Health Administration, University of South Florida College of Public Health
BS, Biochemistry and Biology, Xavier University of Louisiana
Research Interests
HIV prevention and risk factors, drug use, misuse, and addiction, social interactions, mental health, health disparities, behavioral economics
BIO
Joyonna Gamble-George is an Associate Research Scientist in Public Health in the Department of Social and Behavioral Sciences at Yale School of Public Health. Previously, she was a NIDA T-32 postdoctoral research fellow in the Behavioral Sciences Training (BST) in Drug Abuse Research program at NYU Meyers College of Nursing. Her current research focuses on the biopsychosocial factors that contribute to mental disorders, substance addiction, and HIV risky behaviors.

Through the AAAS Science and Technology Policy Fellowship at the National Institutes of Health, Dr. Gamble-George previously served as an expert science advisor for doctors, psychologists, nurses, and other scientists across the United States that conduct implementation science research on cardiopulmonary diseases and mental health in vulnerable populations, such as people living with HIV. She also completed postdoctoral training at the University of Florida McKnight Brain Institute, where her research focused on the effects of methamphetamine on bidirectional neuron-microglia communication in the human brain and animal models of HIV-1 infection. Her other research efforts concerned the molecular and synaptic consequences of drug abuse and addiction, and the endocannabinoid signaling in affective disorder pathology.
Publications

Recent

Ransome Y, Hayashi K, Gamble-George JC, Dean LT, Villalonga-Olives E (2023).
Racial and ethnic differences in the association of social cohesion and social capital with HIV testing
SSM Population Health, 21, 101327. doi: 10.1016/j.ssmph.2022.101327. PMCID: PMC9811247.

Greenwood GL, Wilson A, Bansal GP, Barnhart C, Barr E, Berzon R, Boyce CA, Elwood W, Gamble-George J, Glenshaw M, Henry R, Iida H, Jenkins RA, Lee S, Malekzadeh A, Morris K, Perrin P, Rice E, Sufian M, Weatherspoon D, Whitaker M, Williams M, Zwerski S, Gaist P (2022).
HIV-related stigma research as a priority at the National Institutes of Health
AIDS and Behavior, 26 (Suppl 1), S5-S26. doi: 10.1007/s10461-021-03260-6. PMCID: PMC8060687.

Opara I, Malik S, Lardier DT, Gamble-George J, Kelly RJ, Okafor CN, Greene RN, Parisi D (2021).
Alcohol use cravings as a mediator between associated risk factors on increased alcohol use among youth adults in New York during the COVID-19 pandemic
Alcoholism Treatment Quarterly, 39 (4), 415-429. doi: 10.1080/07347324.2021.1950091.

Gamble-George JC, Longenecker CT, Webel AR, Au DH, Brown AF, Bosworth H, Crothers K, Cunningham WE, Fiscella KA, Hamilton AB, Helfrich CD, Ladapo JA, Luque A, Tobin JN, Wyatt GE, Implementation Research to Develop Interventions for People Living with HIV (PRECluDE) Consortium (2020).
ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research
Progress in Cardiovascular Disease, 63 (2), 79-91. doi: 10.1016/j.pcad.2020.03.006. PMCID: PMC7237329.

Dr. Gamble-George's MyBibliography Profile